Politics Zealand stock falls 35% after trial setback, CEO remains optimistic Finance News Mar 6, 2026 Wegovy is produced by pharmaceutical company Novo Nordisk and has been approved for specifically for chronic weight… Read More...
Politics Why Novo Nordisk’s Ireland expansion is key to fighting off Eli Lilly Finance News Mar 2, 2026 Novo Nordisk is investing 432 million euros ($506 million) in a facility in Ireland as it expands its production… Read More...
Retail Jim Cramer’s update on our AI stocks and the rest of the portfolio Finance News Mar 2, 2026 On Friday, the CNBC Investing Club held its February Monthly Meeting, where Jim Cramer and Director of Portfolio… Read More...
Politics These 4 charts show the scale of Novo Nordisk’s woes Finance News Feb 25, 2026 Novo Nordisk was the first company to make a GLP-1 drug for weight loss and became Europe's most valuable company.But… Read More...
Business Eli Lilly launches Zepbound obesity drug pen with one month of doses Finance News Feb 23, 2026 An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York on March 28, 2024.Shelby… Read More...
Politics Novo Nordisk stock falls as weight loss drug fails to beat Eli Lilly Finance News Feb 23, 2026 The Novo Nordisk A/S headquarters in Bagsvaerd, Denmark, on Wednesday, Nov. 5, 2025. Nichlas Pollier | Bloomberg |… Read More...
Business More drugs should be over-the-counter Finance News Feb 18, 2026 Food and Drug Administration Commissioner Marty Makary told CNBC that he believes "everything should be over the… Read More...
Business Novo Nordisk faces defining year in the obesity drug market Finance News Feb 16, 2026 Mike Doustdar, CEO of Novo Nordisk, speaks in the Oval Office during an event about weight loss drugs at the White… Read More...
Politics Prices, pipelines and patent cliffs: Inside pharma’s big reset Finance News Feb 13, 2026 This earnings season, Europe's biggest pharma companies posted results ranging from 7% beats to 3% misses — but no… Read More...
Politics Medicare coverage opens 15 million-patient opportunity Finance News Feb 11, 2026 Novo Nordisk CEO Mike Doustdar.CNBCNovo Nordisk CEO Mike Doustdar on Wednesday said the company is aiming to capture… Read More...